{"title":"Epigenome editing-mediated restoration of FBN1 expression by demethylation of CpG island shore in porcine fibroblasts","authors":"Rio Miyadai , Shiori Hinata , Yuya Amemiya , Satori Shigematsu , Kazuhiro Umeyama , Hiroshi Nagashima , Kenji Yamatoya , Jun Ohgane","doi":"10.1016/j.bbrep.2025.101973","DOIUrl":null,"url":null,"abstract":"<div><div>Fibrillin-1, an extracellular matrix protein encoded by the <em>FBN1</em> gene, is crucial for maintaining connective tissue integrity. Mutations in <em>FBN1</em> result in haploinsufficiency, leading to Marfan syndrome, in which the expression of functional <em>FBN1</em> is correlated with disease onset and severity. Recent studies suggest that <em>FBN1</em> expression is modulated by DNA methylation, particularly within the CpG island shores of its promoter region. In porcine models, <em>FBN1</em> mRNA levels have been found to correlate with the proportion of hypomethylated alleles in the CpG island shore region. In this study, we employed epigenome editing using the dCas9-TET1 system to induce targeted DNA demethylation within the <em>FBN1</em> CpG island shore, which became hypermethylated after a prolonged culture of porcine fetal fibroblast cells. This approach effectively reduced methylation in the targeted region, and cells expressing the dCas9-TET1 system maintained hypomethylation across multiple passages. Critically, DNA demethylation of the <em>FBN1</em> CpG island shore restored <em>FBN1</em> expression in heterozygous <em>FBN1</em> knockout fibroblasts, which developed stochastic hypermethylation after extended culture. These findings highlight the potential of DNA methylation manipulation to restore <em>FBN1</em> expression in cells with a haploinsufficient genetic background.</div></div>","PeriodicalId":8771,"journal":{"name":"Biochemistry and Biophysics Reports","volume":"42 ","pages":"Article 101973"},"PeriodicalIF":2.3000,"publicationDate":"2025-03-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biochemistry and Biophysics Reports","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2405580825000603","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Fibrillin-1, an extracellular matrix protein encoded by the FBN1 gene, is crucial for maintaining connective tissue integrity. Mutations in FBN1 result in haploinsufficiency, leading to Marfan syndrome, in which the expression of functional FBN1 is correlated with disease onset and severity. Recent studies suggest that FBN1 expression is modulated by DNA methylation, particularly within the CpG island shores of its promoter region. In porcine models, FBN1 mRNA levels have been found to correlate with the proportion of hypomethylated alleles in the CpG island shore region. In this study, we employed epigenome editing using the dCas9-TET1 system to induce targeted DNA demethylation within the FBN1 CpG island shore, which became hypermethylated after a prolonged culture of porcine fetal fibroblast cells. This approach effectively reduced methylation in the targeted region, and cells expressing the dCas9-TET1 system maintained hypomethylation across multiple passages. Critically, DNA demethylation of the FBN1 CpG island shore restored FBN1 expression in heterozygous FBN1 knockout fibroblasts, which developed stochastic hypermethylation after extended culture. These findings highlight the potential of DNA methylation manipulation to restore FBN1 expression in cells with a haploinsufficient genetic background.
期刊介绍:
Open access, online only, peer-reviewed international journal in the Life Sciences, established in 2014 Biochemistry and Biophysics Reports (BB Reports) publishes original research in all aspects of Biochemistry, Biophysics and related areas like Molecular and Cell Biology. BB Reports welcomes solid though more preliminary, descriptive and small scale results if they have the potential to stimulate and/or contribute to future research, leading to new insights or hypothesis. Primary criteria for acceptance is that the work is original, scientifically and technically sound and provides valuable knowledge to life sciences research. We strongly believe all results deserve to be published and documented for the advancement of science. BB Reports specifically appreciates receiving reports on: Negative results, Replication studies, Reanalysis of previous datasets.